Xu Rui (Ryan Xu) is Head of Overseas Affairs of the Medphoenix Group and CEO of GoldenWing Medical Inc. in California, USA. He specializes in preclinical research, GLP compliance and global registration for medical devices, and has built the "China R&D + Global Validation" go-global model. Backed by three GLP laboratories in Suzhou, Taizhou and California plus overseas partners, his one-stop chain — animal studies, overseas clinical trials, global registration and supply chain — has helped Chinese innovations such as artificial hearts and heart valves open the doors of U.S. and European markets. With a professional perspective spanning both pharma and devices, and a track record of speaking at international industry events and judging medical device innovation competitions, he remains, with a broad global outlook and dual-field expertise, an active driver of two-way translation of innovative medical technology between China and the world.